Conference
Study design of an efficacy and safety phase 3, randomized, double-blind, placebo-controlled trial of APL-130277 in the treatment of OFF episodes (CTH-300)
Authors
Olanow CW; Pappert E; Gardzinski P; Dzyngel B; Agro A
Volume
32
Pagination
pp. S36-S37
Publisher
WILEY
Publication Date
February 1, 2017
Name of conference
1st Pan American Parkinson's Disease and Movement Disorders Congress
Conference place
Miami, FL
Conference start date
February 24, 2017
Conference end date
February 26, 2017
Conference proceedings
MOVEMENT DISORDERS
ISSN
0885-3185